CELLDEX THERAPEUTICS INC NEW shareholders Q3 2023

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.

CELLDEX THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
MetLife Investment Management, LLC 24,073$662,4890.01%
Ensign Peak Advisors, Inc 92,129$2,535,3900.01%
Cutler Group LLC / CA 1,500$410.00%
AMERICAN INTERNATIONAL GROUP, INC. 23,187$638,1060.00%
METROPOLITAN LIFE INSURANCE CO/NY 2,731$75,1570.00%
DIMENSIONAL FUND ADVISORS LP 341,350$9,394,4060.00%
Connor, Clark & Lunn Investment Management Ltd. 18,155$499,6260.00%
NORTHERN TRUST CORP 473,920$13,042,2780.00%
Arizona State Retirement System 11,436$314,7190.00%
AMERICAN CENTURY COMPANIES INC 160,860$4,426,8650.00%
STATE OF WISCONSIN INVESTMENT BOARD 31,949$879,2360.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 361,547$9,949,7730.00%
BNP PARIBAS FINANCIAL MARKETS 91,723$2,524,2170.00%
GEODE CAPITAL MANAGEMENT, LLC 1,000,425$27,535,0770.00%
STATE STREET CORP 2,292,851$63,099,2600.00%
BlackRock Inc. 3,251,954$89,493,7760.00%
VANGUARD GROUP INC 2,618,504$72,061,2300.00%
LOS ANGELES CAPITAL MANAGEMENT LLC 16,082$442,5770.00%
MILLENNIUM MANAGEMENT LLC 158,157$4,352,4810.00%
TD ASSET MANAGEMENT INC 64,922$1,786,6530.00%
External links

This page lists CELLDEX THERAPEUTICS INC NEW's shareholders in Q3 2023. To view CELLDEX THERAPEUTICS INC NEW's shareholder history, click here.